| scholarly article | Q13442814 |
| P50 | author | Pascale Krejbich-Trotot | Q45880107 |
| Jean-Jacques Hoarau | Q45880197 | ||
| Philippe Gasque | Q59668588 | ||
| Ghislaine Li-Pat-Yuen | Q59668714 | ||
| Marc Grandadam | Q66388950 | ||
| Vincent Vieillard | Q91338998 | ||
| Frederick Gay | Q123571351 | ||
| Brigitte Autran | Q15406961 | ||
| Patrice Debré | Q33102399 | ||
| P2093 | author name string | Hugues Tolou | |
| Anne Ribera | |||
| Jean-Jacques Hoarau | |||
| Mélanie Denizot | |||
| Trina Das | |||
| Tawfiq Henni | |||
| Philippe Morbidelli | |||
| Frank Tallet | |||
| Michel Jolivet | |||
| Marie-Christine Jaffar Bandjee | |||
| Sandrine Bruniquet | |||
| Bérengère Dassa | |||
| Bernard Alex Gauzère | |||
| Elsa Guichard | |||
| Gérard Martigny | |||
| Marie Pierre Moiton | |||
| Zaïnoul Jaffar Bandjee | |||
| P2860 | cites work | Multidisciplinary Prospective Study of Mother-to-Child Chikungunya Virus Infections on the Island of La Réunion | Q27485485 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chikungunya | Q243257 |
| Chikungunya virus | Q15794049 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 5914-5927 | |
| P577 | publication date | 2010-04-19 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | |
| P478 | volume | 184 |
| Q35675871 | A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation |
| Q40288450 | A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal |
| Q35641902 | A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection |
| Q36506753 | A chimeric vesiculo/alphavirus is an effective alphavirus vaccine |
| Q90263559 | A comparison of Chikungunya virus infection, progression, and cytokine profiles in human PMA-differentiated U937 and murine RAW264.7 monocyte derived macrophages |
| Q34756658 | A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence |
| Q28533408 | A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease |
| Q37643733 | A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection. |
| Q26700129 | A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis |
| Q57091720 | A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control |
| Q38329445 | A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization |
| Q36827438 | A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts |
| Q39458858 | Age has a role in driving host immunopathological response to alphavirus infection. |
| Q30240216 | Animal Models of Chikungunya Virus Infection and Disease. |
| Q89794663 | Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection |
| Q47547788 | Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity |
| Q21284682 | Antiviral perspectives for chikungunya virus |
| Q63246307 | Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease |
| Q24701798 | Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss |
| Q34273343 | Arthritogenic alphaviruses--an overview |
| Q28119393 | Assay optimization for molecular detection of Zika virus |
| Q34275095 | Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 viruses |
| Q37711813 | Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus |
| Q37713542 | Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection |
| Q24701763 | Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection |
| Q37765475 | Biology and pathogenesis of chikungunya virus |
| Q93108577 | Bioluminescent Ross River Virus Allows Live Monitoring of Acute and Long-Term Alphaviral Infection by In Vivo Imaging |
| Q33785818 | Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients |
| Q34810471 | CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice. |
| Q24701757 | Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology |
| Q58575620 | Cellular and Molecular Immune Response to Chikungunya Virus Infection |
| Q28551420 | Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses |
| Q30235585 | Chikungunya Infection: a Global Public Health Menace |
| Q39018616 | Chikungunya Pathogenesis: From the Clinics to the Bench |
| Q27928037 | Chikungunya Virus Infection: An Update on Joint Manifestations and Management |
| Q41931672 | Chikungunya Virus Infection: Why Should U.S. Geriatricians Be Aware of It? |
| Q41923135 | Chikungunya Virus-Associated Disease |
| Q97518511 | Chikungunya Virus: An Emergent Arbovirus to the South American Continent and a Continuous Threat to the World |
| Q38874607 | Chikungunya Virus: Current Perspectives on a Reemerging Virus. |
| Q90148719 | Chikungunya arthritis |
| Q34222718 | Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia |
| Q27305283 | Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean |
| Q59360387 | Chikungunya fever: a threat to global public health |
| Q38118022 | Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy |
| Q42710574 | Chikungunya fever: focus on peripheral markers of pathogenesis |
| Q38560348 | Chikungunya triggers an autophagic process which promotes viral replication |
| Q26700081 | Chikungunya vaccines in development |
| Q36114846 | Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis |
| Q29353678 | Chikungunya virus and its mosquito vectors |
| Q36582816 | Chikungunya virus and prospects for a vaccine |
| Q89899047 | Chikungunya virus evades antiviral CD8+ T cell responses to establish persistent infection in joint-associated tissues |
| Q59350996 | Chikungunya virus fidelity variants exhibit differential attenuation and population diversity in cell culture and adult mice |
| Q57023103 | Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment |
| Q24497757 | Chikungunya virus infection |
| Q54225114 | Chikungunya virus infection in Aruba: Diagnosis, clinical features and predictors of post-chikungunya chronic polyarthralgia. |
| Q35586877 | Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants |
| Q38527379 | Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines. |
| Q21562246 | Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study |
| Q30235512 | Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies |
| Q38666344 | Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies. |
| Q24701786 | Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes |
| Q34234324 | Chikungunya: a re-emerging virus |
| Q26771903 | Chikungunya: bending over the Americas and the rest of the world |
| Q42987420 | Chikungunya: out of the tropical forests and heading our way …. |
| Q36828876 | Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms? |
| Q34378105 | Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response |
| Q90440599 | Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody |
| Q37725255 | Closing the gap between viral and noninfectious arthritis |
| Q44843600 | Co-infection with Chikungunya virus alters trafficking of pathogenic CD8(+) T cells into the brain and prevents Plasmodium-induced neuropathology |
| Q35053333 | Combined miRNA and mRNA signature identifies key molecular players and pathways involved in chikungunya virus infection in human cells |
| Q34341822 | Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model |
| Q56965879 | Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases |
| Q33615933 | Comprehensive proteomic analysis of white blood cells from chikungunya fever patients of different severities |
| Q61795524 | Control of Acute Arboviral Infection by Natural Killer Cells |
| Q40217985 | Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection |
| Q24701738 | Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection. |
| Q27675532 | Crystal Structure of Aura Virus Capsid Protease and Its Complex with Dioxane: New Insights into Capsid-Glycoprotein Molecular Contacts |
| Q39275761 | Deciphering the differential response of two human fibroblast cell lines following Chikungunya virus infection |
| Q37065242 | Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model |
| Q59350720 | Defining a correlate of protection for chikungunya virus vaccines |
| Q35109218 | Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design |
| Q40254655 | Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice |
| Q92982929 | Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA |
| Q36455781 | Detection of Persistent Chikungunya Virus RNA but not Infectious Virus in Experimental Vertical Transmission in Aedes aegypti from Malaysia |
| Q24701756 | Detection of chikungunya virus antigen by a novel rapid immunochromatographic test |
| Q44843505 | Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya |
| Q28284392 | Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2α phosphorylation |
| Q66678852 | Distinguishing patients with laboratory-confirmed chikungunya from dengue and other acute febrile illnesses, Puerto Rico, 2012-2015 |
| Q30394063 | Dysregulated TGF-β Production Underlies the Age-Related Vulnerability to Chikungunya Virus |
| Q35808631 | Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection |
| Q38707770 | Ebola Virus Disease in Humans: Pathophysiology and Immunity |
| Q107203057 | Ebola virus disease |
| Q37785544 | Emergence and clinical insights into the pathology of Chikungunya virus infection |
| Q100751555 | Engineering a fidelity-variant live-attenuated vaccine for chikungunya virus |
| Q24701768 | Envelope specific T cell responses & cytokine profiles in chikungunya patients hospitalized with different clinical presentations |
| Q92855612 | Establishment of a Cell Culture Model of Persistent Flaviviral Infection: Usutu Virus Shows Sustained Replication during Passages and Resistance to Extinction by Antiviral Nucleosides |
| Q92021203 | Estimating the cost of illness and burden of disease associated with the 2014-2015 chikungunya outbreak in the U.S. Virgin Islands |
| Q44169670 | Evaluation of a range of mammalian and mosquito cell lines for use in Chikungunya virus research |
| Q50099518 | Evidence of previous but not current transmission of chikungunya virus in southern and central Vietnam: Results from a systematic review and a seroprevalence study in four locations |
| Q92072015 | Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate |
| Q24701758 | Expanding Regulatory T Cells Alleviates Chikungunya Virus-Induced Pathology in Mice |
| Q28656413 | Fingolimod treatment abrogates chikungunya virus–induced arthralgia |
| Q29353555 | First Chikungunya Outbreak in Suriname; Clinical and Epidemiological Features |
| Q59351130 | Following in the Footsteps of the Chikungunya Virus in Brazil: The First Autochthonous Cases in Amapá in 2014 and Its Emergence in Rio de Janeiro during 2016 |
| Q37331952 | Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis |
| Q36303514 | Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus |
| Q59353759 | Genetic control of alphavirus pathogenesis |
| Q37900420 | Genomic evolution and phenotypic distinctions of Chikungunya viruses causing the Indian Ocean outbreak |
| Q38234431 | Global protein profiling studies of chikungunya virus infection identify different proteins but common biological processes |
| Q93014216 | Granzyme A in Chikungunya and Other Arboviral Infections |
| Q40301923 | High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand |
| Q78177437 | Host nutritional status affects alphavirus virulence, transmission, and evolution. |
| Q38999094 | How many patients with post-chikungunya chronic inflammatory rheumatism can we expect in the new endemic areas of Latin America? |
| Q59354717 | Human CD8 T-cell activation in acute and chronic chikungunya infection |
| Q34058142 | ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation |
| Q35078457 | Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island |
| Q34982662 | Identification and characterization of a ross river virus variant that grows persistently in macrophages, shows altered disease kinetics in a mouse model, and exhibits resistance to type I interferon |
| Q28534763 | Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library |
| Q39013750 | Immune-Mediated Protection and Pathogenesis of Chikungunya Virus |
| Q66679275 | Immunoglobulin Therapy in a Patient With Severe Chikungunya Fever and Vesiculobullous Lesions |
| Q58801220 | Immunomodulatory drug methotrexate used to treat patients with chronic inflammatory rheumatisms post-chikungunya does not impair the synovial antiviral and bone repair responses |
| Q66679236 | Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence |
| Q38912574 | Imported cases of Chikungunya in Barcelona in relation to the current American outbreak. |
| Q39024665 | Improved detection of genus-specific Alphavirus using a generic TaqMan® assay |
| Q34391631 | Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus |
| Q47289858 | Inflammatory monocytes mediate control of acute alphavirus infection in mice. |
| Q44843636 | Interferon regulated gene (IRG) expression-signature in a mouse model of chikungunya virus neurovirulence |
| Q24598171 | Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock |
| Q44849436 | Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts |
| Q42705670 | Limitations of Current in Vivo Mouse Models for the Study of Chikungunya Virus Pathogenesis |
| Q35027794 | Lipopolysaccharide inhibits Sindbis virus-induced IP-10 release in human peripheral blood mononuclear cells |
| Q24701739 | Long-Term Arthralgia after Mayaro Virus Infection Correlates with Sustained Pro-inflammatory Cytokine Response |
| Q24288747 | Longitudinal Analysis of Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected Patients |
| Q47242810 | Lower temperatures reduce type I interferon activity and promote alphaviral arthritis |
| Q38659305 | MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE. |
| Q37229642 | Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection |
| Q100504004 | Macrophage scavenger receptor 1 controls Chikungunya virus infection through autophagy in mice |
| Q40088877 | Macrophages as target cells for Mayaro virus infection: involvement of reactive oxygen species in the inflammatory response during virus replication |
| Q39128266 | Management of chikungunya arthritis |
| Q93016784 | Mayaro Virus Infects Human Chondrocytes and Induces the Expression of Arthritis-Related Genes Associated with Joint Degradation |
| Q27468832 | Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells |
| Q28535269 | Methotrexate treatment causes early onset of disease in a mouse model of Ross River virus-induced inflammatory disease through increased monocyte production |
| Q54111086 | Miltefosine inhibits Chikungunya virus replication in human primary dermal fibroblasts. |
| Q28114682 | Molecular Virologic and Clinical Characteristics of a Chikungunya Fever Outbreak in La Romana, Dominican Republic, 2014 |
| Q41857816 | Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis |
| Q58723116 | Monocytes and Macrophages as Viral Targets and Reservoirs |
| Q39223670 | Mouse macrophage innate immune response to Chikungunya virus infection |
| Q37993737 | Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology |
| Q24701792 | Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection |
| Q24701750 | Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2 |
| Q42157593 | Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model |
| Q93062220 | MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2 |
| Q35799153 | Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells |
| Q35591444 | NK cells: immune cross-talk and therapeutic implications |
| Q36665279 | Neuropathogenesis of Chikungunya infection: astrogliosis and innate immune activation |
| Q34916476 | Neutralization activity of patient sera collected during the 2008-2009 Chikungunya outbreak in Thailand |
| Q92667794 | Newer rehabilitation therapies: strategies in chikungunya chronic arthralgia |
| Q26782722 | Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model) |
| Q56448842 | Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological Study |
| Q91842996 | Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes |
| Q34611938 | Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses |
| Q40235356 | Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis |
| Q64118754 | P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages |
| Q54207858 | Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection. |
| Q37214518 | Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence |
| Q33793512 | Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study |
| Q28804036 | Persistent RNA virus infections: do PAMPS drive chronic disease? |
| Q57905120 | Persistent Replication of a Chikungunya Virus Replicon in Human Cells Is Associated with Presence of Stable Cytoplasmic Granules Containing Nonstructural Protein 3 |
| Q40160164 | Persistent arthralgia and related risks factors in laboratory-confirmed cases of Chikungunya virus infection in Mexico |
| Q24625887 | Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor |
| Q28119379 | Pharmacologic management of pain in patients with Chikungunya: a guideline |
| Q36012210 | Phenotypic and functional analyses of NK and NKT-like populations during the early stages of chikungunya infection |
| Q58698800 | Plasmodium co-infection protects against chikungunya virus-induced pathologies |
| Q21195256 | Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study |
| Q38789052 | Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis |
| Q90262637 | Prevalence of chronic chikungunya and associated risks factors in the French West Indies (La Martinique): A prospective cohort study |
| Q40117821 | Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology |
| Q40313646 | Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis |
| Q38586243 | Protective and Pathogenic Responses to Chikungunya Virus Infection |
| Q28804081 | RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation |
| Q24701728 | Rainbow trout (Oncorhynchus mykiss) muscle satellite cells are targets of salmonid alphavirus infection |
| Q24701780 | Reemergence of chikungunya virus |
| Q37628200 | Regulation of Viral Replication, Apoptosis and Pro-Inflammatory Responses by 17-AAG during Chikungunya Virus Infection in Macrophages |
| Q44843647 | Regulation of the chikungunya-virus-induced innate inflammatory response by protein tyrosine phosphatase non-receptor 6 in muscle cells |
| Q38608790 | Regulatory T cells and IL-10 as modulators of chikungunya disease outcome: a preliminary study |
| Q40045437 | Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus |
| Q24701776 | Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice |
| Q93087252 | Rheumatic manifestations of chikungunya: emerging concepts and interventions |
| Q55312161 | Rheumatism and chronic fatigue, the two facets of post-chikungunya disease: the TELECHIK cohort study on Reunion island. |
| Q39642986 | Risk of transfusion-transmitted chikungunya infection and efficacy of blood safety implementation measures: experience from the 2009 epidemic in Songkhla Province, Thailand |
| Q90176814 | Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity |
| Q42199381 | Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial |
| Q38791306 | Sequelae of Ebola virus disease: the emergency within the emergency |
| Q57091906 | Seroprevalence and Symptomatic Attack Rate of Chikungunya Virus Infection, United States Virgin Islands, 2014-2015 |
| Q54253650 | Seroprevalence of Chikungunya Virus after Its Emergence in Brazil. |
| Q33634555 | Simultaneous detection of chikungunya virus, dengue virus and human pathogenic Leptospira genomes using a multiplex TaqMan® assay |
| Q30251764 | Sindbis virus as a human pathogen-epidemiology, clinical picture and pathogenesis |
| Q35168183 | Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012. |
| Q40204511 | TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus |
| Q54268571 | The Alphavirus Exit Pathway: What We Know and What We Wish We Knew. |
| Q64063959 | The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis |
| Q57807849 | The Cytokine Profile in Acute Chikungunya Infection is Predictive of Chronic Arthritis 20 Months Post Infection |
| Q52310640 | The Efficacy of the Interferon Alpha/Beta Response versus Arboviruses Is Temperature Dependent. |
| Q47114992 | The Identification of Risk Factors for Chronic Chikungunya Arthralgia in Grenada, West Indies: A Cross-Sectional Cohort Study |
| Q35838581 | The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation |
| Q40283972 | The cell biology of Chikungunya virus infection |
| Q38745944 | The growth of arthralgic Ross River virus is restricted in human monocytic cells. |
| Q36275851 | The neutralizing role of IgM during early Chikungunya virus infection |
| Q33853893 | Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques |
| Q62737885 | Tropism of the Chikungunya Virus |
| Q34037685 | Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity |
| Q28504479 | Viperin restricts chikungunya virus replication and pathology |
| Q37438906 | Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice |
| Q35181923 | Xenosurveillance: a novel mosquito-based approach for examining the human-pathogen landscape |
| Q61446026 | controls chikungunya virus-specific pathogenic T cell IFNγ Th1 stimulation in mice |
Search more.